Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.87%
#3 Nockchain Nockchain +22.61%
#4 Fabric Protocol Fabric Protocol +19.38%
#5 Bedrock Bedrock +16.78%
#6 Cysic Cysic +15.00%
#7 Perle Perle +12.14%
#8 Tutorial Tutorial +6.24%
#9 Anvil Anvil +6.20%
#10 Arowana Arowana +6.03%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
株式のランク #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
株価
$0.07
最終同期: 2024-11-12
時価総額
$1.62M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Peak Bio, Inc. (PKBO)

カテゴリー

Healthcare
Peak Bio, Inc.（PKBO）のEPS
2026 時点のEPS TTM: 0
Peak Bio, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Peak Bio, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE